Organization | Pharmacare PLC, Palestine

Pharmacare PLC, Palestine Report issue

For profit Phase 1 Phase 4

Founded: Betunia Palestine (1985)

Status: No NME R&D (1985)

Organization Overview

First Clinical Trial

2011

NCT02519010

First Marketed Drug

1985

terbutaline (bricanyl)

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

PHARMACARE | Pharmacare Laboratories pharmacare.com.au | PHARMACARE LTD

Active Ingredients

Marketed Drugs (8)

atazanavir (reyataz) (2017)

efavirenz (sustiva) (2017)

lamivudine (epivir) (2005)

nevirapine (viramune) (2005)

stavudine (zerit) (2009)

tenofovir (viread) (2016)

terbutaline (bricanyl) (1981)

zidovudine (retrovir) (2005)

Drugs in Phase 4 Trials (1)

european elderberry (1 trial)

Drugs in Phase 1 Trials (3)

amlodipine (norvasc) (1 trial)

oseltamivir (tamiflu) (1 trial)

valsartan (diovan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Influenza, Human (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 3
# of Trial APIs: 4